MYL

Mylan Inc. News Headlines

$31.27
*  
0.60
  negative  
1.88%
Get MYL Alerts
*Delayed - data as of Jun. 19, 2013 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

Reports: Actavis Spurns $15 Bln Bid From Mylan To Pursue Warner Chilcott Deal
5/14/2013 10:36:00 PM - RTT News

Billionaire John Paulson's Long-Term Stock Picks
5/7/2013 10:57:00 AM - Seeking Alpha

Valeant Misses Earnings and Revenue Estimate in 1Q (Revised) - Analyst Blog
5/7/2013 9:27:01 AM - Zacks.com

Valeant Beats Earnings, Misses Revs - Analyst Blog
5/3/2013 1:31:46 PM - Zacks.com

Mylan Reports in line Earnings - Analyst Blog
5/3/2013 8:31:34 AM - Zacks.com

Mylan Q1 Profit Declines - Update
5/2/2013 6:17:00 PM - RTT News

Mylan Q1 Profit Down 17.2%, Reaffirms FY13 Outlook - Quick Facts
5/2/2013 4:15:00 PM - RTT News

Mylan Q1 13 Earnings Conference Call At 4:30 PM ET
5/2/2013 2:59:00 PM - RTT News

After-Hours Earnings Report for May 2, 2013 : GILD, AIG, CNQ, LNKD, MYL, WFT, FLR, XL, TDC, MHK, MCHP, CPT
5/2/2013 2:00:05 PM - NASDAQ.com News

Orphan Drug Status for Teva/Xenon Drug - Analyst Blog
4/26/2013 4:22:50 PM - Zacks.com

After Hours Most Active for Apr 25, 2013 : ORI, PLD, MO, MSFT, DAL, JCP, GM, NTAP, MU, MYL, QQQ, AMZN
4/25/2013 4:44:56 PM - NASDAQ.com News

Mylan Shows Great Potential For Growth
4/22/2013 11:22:00 PM - Seeking Alpha

Favorable Court Ruling for Actavis - Analyst Blog
4/19/2013 6:13:27 PM - Zacks.com

Data on Teva's Milprosa - Analyst Blog
4/18/2013 7:13:34 PM - Zacks.com

Teva More Undervalued Than Mylan, Looks Towards Technology
4/18/2013 5:56:00 AM - Seeking Alpha

Still Neutral on Mylan - Analyst Blog
4/15/2013 6:20:01 PM - Zacks.com

Good News for Warner Chilcott - Analyst Blog
4/15/2013 5:50:01 PM - Zacks.com

Actavis Settles with Valeant - Analyst Blog
4/11/2013 1:09:46 PM - Zacks.com

TRO on Actavis Sale of Generic Pulmicort Respules - Analyst Blog
4/10/2013 10:50:01 AM - Zacks.com

Valeant Inks Deal with Actavis - Analyst Blog
4/8/2013 5:07:27 PM - Zacks.com

Can Teva's Short-Term Pressure Be Justified?
4/5/2013 3:05:00 PM - Seeking Alpha

Setback for Valeant Pharma - Analyst Blog
4/5/2013 1:09:47 PM - Zacks.com

Dr. Reddy's Launches Generic Reclast - Analyst Blog
4/4/2013 7:06:11 PM - Zacks.com

Another Generic Launch at Mylan - Analyst Blog
4/4/2013 3:09:14 PM - Zacks.com

Valeant Pharma To Take Earnings Hit On Mylan's Zovirax Generic Launch
4/4/2013 10:38:00 AM - RTT News